U.S. appeals court says Trump cannot dodge foreign corruption lawsuit
A U.S. federal appeals court on Friday revived a lawsuit alleging President Donald Trump violated the U.S. Constitution by profiting from foreign and domestic officials...
VW CEO shifts strategy from empire building to efficiency
Volkswagen has abandoned its decades-old obsession with empire building and no-expense-spared engineering to free up resources for the development and mass production of electric cars,...
Debate night split screen highlights the Democrats’ Trump challenge – NBC News
Debate night split screen highlights the Democrats’ Trump challenge NBC News A strong night for Biden and Booker The Boston Globe Winners and losers from the third...
Exclusive: WeWork considers dramatic valuation cut in IPO
WeWork owner The We Company may seek a valuation in its upcoming initial public offering of between $10 billion and $12 billion, a dramatic discount...
Apple, Broadcom rein in Wall Street gains on trade optimism
Losses in shares of U.S. technology majors Apple and Broadcom set Wall Street for a subdued end to the week, as traders balanced the latest...
Patriots WR Brown avoids exempt list, can play Week 2
Antonio Brown is eligible to play Sunday when the New England Patriots visit the Miami Dolphins....
Democratic Debate #3 Ratings Surge For ABC As Biden & Warren Finally Share Stage – Deadline
Democratic Debate #3 Ratings Surge For ABC As Biden & Warren Finally Share Stage Deadline Bernie Sanders on health care: Joe Biden doesn’t know what he’s...
Dorian forces Bahamas to find new schools for 10,000 displaced students
Bahamaian education officials are scrambling to find classroom space for up to 10,000 students displaced by Hurricane Dorian after the Category 5 storm ravaged two...
Hong Kong exchange vows to press on with $39 billion LSE bid after rebuff
Hong Kong’s exchange refused to give up on its bid to take over the London Stock Exchange after the British bourse emphatically rejected its $39...
Biogen scraps two late-stage trials for Alzheimer’s treatment
Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer’s treatment in a widely anticipated move that comes months after the...